NASDAQ · PFSA
Profusa, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for PFSA: Nov 18, 2026
Profusa, Inc. Common Stock is estimated to report earnings on 11/18/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-99.99.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews- RTTNews · Sep 24, 3:06 PM EDTBiotech Stocks On The Move – APUS, PFSA, GCTK, ARCT(RTTNews) – The following biotech stocks were in focus on September 24, 2026, following notable stock moves and company-specific developments involving clinical programs, regulatory progress, financing and technology platforms.
- RTTNews · Sep 24, 8:02 AM EDTProfusa Advances Lumee Oxygen Platform Toward CE Mark(RTTNews) – Profusa, Inc. (PFSA) announced on Thursday that it has received a positive decision from GMED regarding certification of its quality management system to ISO 13485, marking progress toward CE marking of its Lumee Oxygen Platform in the European Union.
- RTTNews · Sep 15, 10:40 AM EDTProfusa Receives Nasdaq Confirmation Of Compliance ;Shares Slide(RTTNews) – Profusa, Inc. (PFSA), a digital health company announced on Tuesday that the company has received a confirmation letter from the Nasdaq stating that the company has demonstrated compliance with Nasdaq's minimum bid price and stockholders' equity requirements.
- RTTNews · Sep 1, 7:23 AM EDTProfusa Resolves Nasdaq Compliance Issue(RTTNews) – Profusa Inc. (PFSA), a commercial-stage digital health company, on Monday reported regaining compliance after receiving a notification from Nasdaq regarding the minimal shares requirement.
- RTTNews · Aug 20, 11:01 AM EDTProfusa Posts Wider Q2 Loss; Progress Toward G3 Vision Labs Option Agreement; Stock Down(RTTNews) – Profusa, Inc. (PFSA), a digital health company developing tissue-integrated biosensors, reported second quarter 2026 results for the period ended June 30, highlighting a wider net loss compared to the prior year and progress on conditions to close its option agreement
- RTTNews · Aug 18, 9:47 AM EDTProfusa's 1-for-4 Reverse Stock Split Becomes Effective; Stock Up 160%(RTTNews) – Profusa, Inc. (PFSA) announced that its previously approved 1-for-4 reverse stock split has taken effect on August 18, 2026. The split consolidates every four shares of common stock into one share, while the par value remains unchanged at $0.0001 per share. Fractional
- RTTNews · Aug 17, 10:11 PM EDTAfter-Hours Gainers: PFSA Executes Another Reverse Split, IVF Jumps On Q2 Results, AMLX Faces D-Day(RTTNews) – Today's after-hours gainers included Profusa, following its latest reverse stock split; INVO Fertility, after reporting second-quarter financial results; Vogenx, which recently made its Nasdaq debut; and Amylyx Pharmaceuticals, whose shares climbed ahead of the compan
- RTTNews · Aug 13, 8:16 AM EDTProfusa Announces 1-for-4 Reverse Stock Split; Shares Slide In Pre-market(RTTNews) – Profusa, Inc. (PFSA), a commercial-stage digital health company developing tissue-integrated biosensors, announced a 1-for-4 reverse stock split of its common stock. The move is intended to adjust the company's capital structure while maintaining its Nasdaq listing.
- RTTNews · Aug 13, 7:27 AM EDTProfusa To Implement 1-For-4 Reverse Stock Split(RTTNews) – Thursday, Profusa, Inc. (PFSA) announced its decision to implement a one-for-four reverse stock split of its common stock, which will take effect on August 17.
- RTTNews · Aug 7, 11:45 AM EDTWeekly Buzz: MRNA, NVS, SNY Gain Approvals; EBS, LSTA Cut Jobs; TARS, BIVI Drive Deals & Data(RTTNews) – This week's biotech roundup captured a mix of regulatory wins, restructuring action, and deal momentum driving sector sentiment. FDA and EU approvals spanned oncology, vaccines and rare disease, while layoffs and cost-saving measures underscored operational tightening
- RTTNews · Aug 3, 4:01 AM EDTProfusa Enters Option Agreement To Acquire G3 Vision Labs; Shares Plunge(RTTNews) – Profusa, Inc. (PFSA), a digital health company, announced the signing of an option agreement that provides Profusa the right and option to acquire G3 Vision Labs, Inc. and its subsidiaries, Med Screen Laboratories Inc., Dominion Diagnostics LLC, and Acutis Diagnostics
- RTTNews · Jul 27, 7:40 AM EDTPFSA Stock Falls 19% Amid Diagnostics Acquisition News(RTTNews) – Profusa, Inc. (PFSA), a digital health company focusing on biosensing technologies, announced that it has signed a non-binding term sheet to acquire of a privately held commercial-stage diagnostics and toxicology testing company.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Profusa, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.